The nutrition research program will be conducted in collaboration with a strategic partner, the Institute of Nutraceuticals and Functional Foods (INAF).
INAF dedicates all of its research efforts to advance knowledge in the area of nutrition and health, with an expertise in studying functional food ingredients and dietary supplements.
Atrium’s research involves understanding of metabolic syndrome and investigating the impact of nutrition on the prevention and treatment of silent inflammation associated with this condition.
Atrium’s research will emphasize the health benefits of small fruits, the anti-inflammatory mechanisms of specific fish oil fractions in the prevention of cardiovascular disease, probiotics and systemic enzyme therapy in the management of inflammation and health promotion.
Atrium Innovations said the total current funding for related projects planned and in progress is over $5m, and includes partial support from governmental agencies.
Atrium Innovations president and CEO Pierre Fitzgibbon said applying a science-based approach to their whole spectrum of products, they have the ability to positively affect the quality of life of people by helping them maintain their health and prevent serious diseases.